Cluster of zoonotic cutaneous leishmaniasis (Leishmania major) in European travelers returning from Turkmenistan

Journal of Travel Medicine

Volumn 20, Issue 6, 2013, Pages 400-402

  Larréché, Sébastien ^a   Launay, Grégoire ^a   Weibel Galluzzo, Christelle ^b   Bousquet, Aurore ^a   Eperon, Gilles ^b   Pilo, Jean Etienne ^a   Ravel, Christophe ^c   Chappuis, François ^b   Dupin, Michel ^a   Mérens, Audrey ^a  

^a Military Teaching Hospital Begin   (France)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c Department of Parasitology   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; FLUCONAZOLE; IMIDAZOLE; IMIQUIMOD; MILTEFOSINE; PENTAMIDINE ISETHIONATE; STIBOGLUCONATE SODIUM; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ANTICOAGULATION; ARTICLE; ASIA; CASE REPORT; CELLULITIS; CRYOTHERAPY; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HUMAN; LEISHMANIA MAJOR; LEISHMANIASIS; LOW DRUG DOSE; MALE; PARASITE VIRULENCE; POLYMERASE CHAIN REACTION; REPEATED DRUG DOSE; SKIN BIOPSY; SKIN LEISHMANIASIS; THROMBOPHLEBITIS; TRAVEL; TREATMENT RESPONSE; TURKMENISTAN; ZOONOSIS;

ADULT; ANTIPROTOZOAL AGENTS; CLUSTER ANALYSIS; CRYOTHERAPY; FEMALE; FRANCE; GREAT BRITAIN; HUMANS; INJECTIONS, INTRAMUSCULAR; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; SKIN; SWITZERLAND; TURKMENISTAN;

EID: 84886950206     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/jtm.12065     Document Type: Article

References (12)

1. Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012; 7: e35671.
2. Reithinger R, Dujardin JC, Louzir H, et al. Cutaneous leishmaniasis. Lancet Infect Dis 2007; 7: 581-596.
3. Foulet F, Botterel F, Buffet P, et al. Detection and identification of Leishmania species from clinical specimens by using a real-time PCR assay and sequencing of the cytochrome B gene. J Clin Microbiol 2007; 45: 2110-2115.
4. Marfurt J, Nasereddin A, Niederwieser I, et al. Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis. J Clin Microbiol 2003; 41: 3147-3153.
5. Faulde MK, Heyl G, Amirih ML,. Zoonotic cutaneous leishmaniasis, Afghanistan. Emerg Infect Dis 2006; 12: 1623-1624.
6. El Hajj L, Thellier M, Carrière J, et al. Localized cutaneous leishmaniasis imported into Paris: a review of 39 cases. Int J Dermatol 2004; 43: 120-125.
7. Faulde MK, Werner A, Heyl G,. Untreated zoonotic cutaneous leishmaniasis characterizing a highly aggressive strain type of Leishmania major in Uzbekistan. J Eur Acad Dermatol Venereol 2007; 21: 1432-1433.
8. Khatami A, Firooz A, Gorouhi F, Dowlati Y,. Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials. J Am Acad Dermatol 2007; 57: 335.e1-29.
9. Blum JA, Hatz CF,. Treatment of cutaneous leishmaniasis in travelers 2009. J Travel Med 2009; 16: 123-131.
10. Emad M, Hayati F, Fallahzadeh MK, Namazi MR,. Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous Leishmania major infection: a randomized clinical trial. J Am Acad Dermatol 2011; 64: 606-608.
11. Jauréguiberry S, Graby G, Caumes E,. Efficacy of short-course intramuscular pentamidine isethionate treatment on Old World localized cutaneous leishmaniasis in 2 patients. Clin Infect Dis 2006; 42: 1812-1813.
12. Hellier I, Dereure O, Tournillac I, et al. Treatment of Old World cutaneous leishmaniasis by pentamidine isethionate. An open study of 11 patients. Dermatology 2000; 200: 120-123.